MetaADEDB 2.0 @ LMMD
Amoxicillin
(MQXQVCLAUDMCEF-CWLIKTDRSA-N)
Structure
SMILES
O=C([C@@H](c1ccc(cc1)O)N)N[C@@H]1C(=O)N2[C@@H]1SC([C@@H]2C(=O)O)(C)C.O.O.O
Molecular Formula:
C16H25N3O8S
Molecular Weight:
419.450
Log P:
0.8599
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
7
TPSA:
185.95
CAS Number(s):
61336-70-7
Synonym(s)
1.
Amoxicillin
2.
Hydroxyampicillin
3.
Actimoxi
4.
Amoxicillin Anhydrous
5.
Amoxicillin Monopotassium Salt
6.
Amoxicillin Monosodium Salt
7.
Amoxicillin Sodium
8.
Amoxicillin Trihydrate
9.
Amoxicillin, (R*)-Isomer
10.
Amoxicilline
11.
Amoxil
12.
Amoxycillin
13.
BRL-2333
14.
Clamoxyl
15.
Clamoxyl G.A.
16.
Clamoxyl Parenteral
17.
Penamox
18.
Polymox
19.
Trimox
20.
Wymox
21.
BRL 2333
22.
BRL2333
External Link(s)
MeSHD000658
PubChem Compound62883
ChEBI51254
KEGGdr:D00229
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PruritusFAERS: 25US FAERS
2UrticariaFAERS: 23US FAERS
3ErythemaFAERS: 18US FAERS
4HypersensitivityFAERS: 14US FAERS
5VomitingFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
6Medication ErrorFAERS: 12US FAERS
7Abdominal PainFAERS: 9US FAERS
8AngioedemaFAERS: 9US FAERS
9MalaiseFAERS: 9US FAERS
10Anaphylactic shockFAERS: 8US FAERS
11Erythema MultiformeFAERS: 8US FAERS
12AstheniaFAERS: 5US FAERS
13ChillsFAERS: 5US FAERS
14Drug exposure during pregnancyFAERS: 5US FAERS
15EczemaFAERS: 5US FAERS
16HeadacheFAERS: 5US FAERS
17HypotensionFAERS: 5US FAERS
18Serum SicknessFAERS: 5US FAERS
19Toxic Epidermal NecrolysisFAERS: 5US FAERS
20AsthmaFAERS: 4US FAERS
21NauseaFAERS: 4US FAERS
22Skin test positiveFAERS: 4US FAERS
23ThrombocytopeniaFAERS: 4US FAERS
24Acute Coronary SyndromeFAERS: 3US FAERS
25BronchospasmFAERS: 3US FAERS
26CholestasisFAERS: 3US FAERS
27ConjunctivitisFAERS: 3US FAERS
28Diabetes mellitus inadequate controlFAERS: 3US FAERS
29Disseminated Intravascular CoagulationFAERS: 3US FAERS
30Drug ineffectiveFAERS: 3US FAERS
31DysphoniaFAERS: 3US FAERS
32EosinophiliaFAERS: 3US FAERS
33InflammationFAERS: 3US FAERS
34LeukocytosisFAERS: 3US FAERS
35Myocardial InfarctionFAERS: 3US FAERS
36Rash erythematousFAERS: 3US FAERS
37Stevens-Johnson SyndromeFAERS: 3US FAERS
38SwellingFAERS: 3US FAERS
39TachycardiaFAERS: 3US FAERS
40Abdominal discomfortFAERS: 2US FAERS
41Acute myocardial infarctionFAERS: 2US FAERS
42AlopeciaFAERS: 2US FAERS
43Angina PectorisFAERS: 2US FAERS
44ArthralgiaFAERS: 2US FAERS
45Blood creatine phosphokinase increasedFAERS: 2US FAERS
46Blood immunoglobulin E increasedFAERS: 2US FAERS
47Burning sensationFAERS: 2US FAERS
48Chest PainFAERS: 2US FAERS
49DeliriumFAERS: 2US FAERS
50Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
51InfectionFAERS: 2US FAERS
52MyalgiaFAERS: 2US FAERS
53PalpitationsFAERS: 2US FAERS
54Pharyngolaryngeal PainFAERS: 2US FAERS
55PrurigoFAERS: 2US FAERS
56Pustular psoriasisFAERS: 2US FAERS
57RhinitisFAERS: 2US FAERS
58Skin lesionFAERS: 2US FAERS
59SomnolenceFAERS: 2US FAERS
60Subcorneal pustular dermatosisFAERS: 2US FAERS
61Transaminases increasedFAERS: 2US FAERS
62TremorFAERS: 2US FAERS
63WheezingFAERS: 2US FAERS
64AcneFAERS: 1US FAERS
65Acquired macroglossiaFAERS: 1US FAERS
66Acute psychosisFAERS: 1US FAERS
67Adverse eventFAERS: 1US FAERS
68AgitationFAERS: 1US FAERS
69Anaphylactoid ReactionFAERS: 1US FAERS
70AnorexiaFAERS: 1US FAERS
71ArthritisFAERS: 1US FAERS
72Atrial FibrillationFAERS: 1US FAERS
73Biopsy liver abnormalFAERS: 1US FAERS
74Blood albumin decreasedFAERS: 1US FAERS
75Blood alkaline phosphatase increasedFAERS: 1US FAERS
76Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
77Blood lactate dehydrogenase increasedFAERS: 1US FAERS
78Blood urine presentFAERS: 1US FAERS
79BradycardiaFAERS: 1US FAERS
80Chest discomfortFAERS: 1US FAERS
81Choking sensationFAERS: 1US FAERS
82CholangitisFAERS: 1US FAERS
83ChromaturiaFAERS: 1US FAERS
84ColitisFAERS: 1US FAERS
85CryingFAERS: 1US FAERS
86CyanosisFAERS: 1US FAERS
87DeafnessFAERS: 1US FAERS
88Deep Vein ThrombosisFAERS: 1US FAERS
89DehydrationFAERS: 1US FAERS
90DermatitisFAERS: 1US FAERS
91DizzinessFAERS: 1US FAERS
92Drug resistanceFAERS: 1US FAERS
93Drug screen false positiveFAERS: 1US FAERS
94Drug toxicityFAERS: 1US FAERS
95Dry skinFAERS: 1US FAERS
96DysuriaFAERS: 1US FAERS
97Emotional distressFAERS: 1US FAERS
98Epigastric discomfortFAERS: 1US FAERS
99Epstein-Barr virus test positiveFAERS: 1US FAERS
100Eye painFAERS: 1US FAERS
101FatigueFAERS: 1US FAERS
102FlushingFAERS: 1US FAERS
103Foreign body aspirationFAERS: 1US FAERS
104FormicationFAERS: 1US FAERS
105GastroenteritisFAERS: 1US FAERS
106HemiplegiaFAERS: 1US FAERS
107HepatotoxicityFAERS: 1US FAERS
108HyperventilationFAERS: 1US FAERS
109HypokinesiaFAERS: 1US FAERS
110IleusFAERS: 1US FAERS
111Impaired work abilityFAERS: 1US FAERS
112Kounis SyndromeFAERS: 1US FAERS
113Limb discomfortFAERS: 1US FAERS
114Live BirthFAERS: 1US FAERS
115Lower respiratory tract infectionFAERS: 1US FAERS
116Lymphocyte stimulation test negativeFAERS: 1US FAERS
117MacroglossiaFAERS: 1US FAERS
118MeningitisFAERS: 1US FAERS
119Metabolic acidosisFAERS: 1US FAERS
120Myoglobin blood decreasedFAERS: 1US FAERS
121Neck PainFAERS: 1US FAERS
122No adverse eventFAERS: 1US FAERS
123Oculomucocutaneous syndromeFAERS: 1US FAERS
124Ophthalmia NeonatorumFAERS: 1US FAERS
125Oropharyngeal painFAERS: 1US FAERS
126OverdoseFAERS: 1US FAERS
127PainFAERS: 1US FAERS
128PemphigusFAERS: 1US FAERS
129Peripheral swellingFAERS: 1US FAERS
130Pharyngeal erosionFAERS: 1US FAERS
131PhonophobiaFAERS: 1US FAERS
132PneumoniaFAERS: 1US FAERS
133Protein urine presentFAERS: 1US FAERS
134ProteinuriaFAERS: 1US FAERS
135Psychomotor skills impairedFAERS: 1US FAERS
136PyuriaFAERS: 1US FAERS
137RalesFAERS: 1US FAERS
138RhabdomyolysisFAERS: 1US FAERS
139ShockFAERS: 1US FAERS
140SplenomegalyFAERS: 1US FAERS
141Staphylococcal Scalded Skin SyndromeFAERS: 1US FAERS
142StomatitisFAERS: 1US FAERS
143Streptococcus test positiveFAERS: 1US FAERS
144Supraventricular tachycardiaFAERS: 1US FAERS
145TetanyFAERS: 1US FAERS
146ThirstFAERS: 1US FAERS
147Troponin I increasedFAERS: 1US FAERS
148Ventricular hypokinesiaFAERS: 1US FAERS
149VertigoFAERS: 1US FAERS
150jaundiceFAERS: 1US FAERS
151Cold sweatCanada Vigilance: 1Canada Vigilance
152Fixed eruptionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.